BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21160767)

  • 1. Telomere function in colorectal cancer.
    Frías C; Morán A; de Juan C; Ortega P; Fernández-Marcelo T; Sánchez-Pernaute A; Torres AJ; Díaz-Rubio E; Benito M; Iniesta P
    World J Gastrointest Oncol; 2009 Oct; 1(1):3-11. PubMed ID: 21160767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
    J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
    Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
    Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomeres and telomerase in the clinical management of colorectal cancer.
    Piñol-Felis C; Fernández-Marcelo T; Viñas-Salas J; Valls-Bautista C
    Clin Transl Oncol; 2017 Apr; 19(4):399-408. PubMed ID: 27761787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status.
    Fernández-Marcelo T; Gómez A; Pascua I; de Juan C; Head J; Hernando F; Jarabo JR; Calatayud J; Torres-García AJ; Iniesta P
    J Exp Clin Cancer Res; 2015 Aug; 34(1):78. PubMed ID: 26250468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere length and hTERT expression in patients with colorectal carcinoma.
    Rosenberg R; Gertler R; Stricker D; Lassmann S; Werner M; Nekarda H; Siewert JR
    Recent Results Cancer Res; 2003; 162():177-81. PubMed ID: 12790332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of retinoblastoma in the absence of telomerase activity.
    Gupta J; Han LP; Wang P; Gallie BL; Bacchetti S
    J Natl Cancer Inst; 1996 Aug; 88(16):1152-7. PubMed ID: 8757195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres.
    Onitake Y; Hiyama E; Kamei N; Yamaoka H; Sueda T; Hiyama K
    J Pediatr Surg; 2009 Dec; 44(12):2258-66. PubMed ID: 20006006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
    Grobelny JV; Kulp-McEliece M; Broccoli D
    Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating Cancer by Targeting Telomeres and Telomerase.
    Ivancich M; Schrank Z; Wojdyla L; Leviskas B; Kuckovic A; Sanjali A; Puri N
    Antioxidants (Basel); 2017 Feb; 6(1):. PubMed ID: 28218725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer].
    Katayama S; Shiota G; Kawasaki H
    Nihon Rinsho; 1998 May; 56(5):1204-8. PubMed ID: 9613123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).
    Engelhardt M; Martens UM
    Oncol Rep; 1998; 5(5):1043-52. PubMed ID: 9683806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in gastric cancer.
    Hiyama E; Yokoyama T; Tatsumoto N; Hiyama K; Imamura Y; Murakami Y; Kodama T; Piatyszek MA; Shay JW; Matsuura Y
    Cancer Res; 1995 Aug; 55(15):3258-62. PubMed ID: 7614459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase and human tumorigenesis.
    Stewart SA; Weinberg RA
    Semin Cancer Biol; 2000 Dec; 10(6):399-406. PubMed ID: 11170862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
    Nittis T; Guittat L; Stewart SA
    Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
    De Vitis M; Berardinelli F; Sgura A
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shorter telomeres and high telomerase activity correlate with a highly aggressive phenotype in breast cancer cell lines.
    Ceja-Rangel HA; Sánchez-Suárez P; Castellanos-Juárez E; Peñaroja-Flores R; Arenas-Aranda DJ; Gariglio P; Benítez-Bribiesca L
    Tumour Biol; 2016 Sep; 37(9):11917-11926. PubMed ID: 27072825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.